US5750561A
(en)
*
|
1991-07-08 |
1998-05-12 |
Rhone-Poulenc Rorer, S.A. |
Compositions containing taxane derivatives
|
US5714512A
(en)
*
|
1991-07-08 |
1998-02-03 |
Rhone-Poulenc Rorer, S.A. |
Compositions containing taxane derivatives
|
CA2086874E
(en)
*
|
1992-08-03 |
2000-01-04 |
Renzo Mauro Canetta |
Methods for administration of taxol
|
GB2269319B
(en)
*
|
1992-08-03 |
1997-04-09 |
Bristol Myers Squibb Co |
Methods for administration of taxol
|
US5684169A
(en)
*
|
1992-11-27 |
1997-11-04 |
Ensuiko Sugar Refining Co., Ltd. |
Cyclodextrin inclusion complex of taxol, and method for its production and its use
|
CA2149150C
(en)
*
|
1992-11-27 |
2000-08-01 |
David R. Carver |
Injectable taxol composition with improved stability
|
JPH06157330A
(ja)
*
|
1992-11-27 |
1994-06-03 |
Ensuiko Sugar Refining Co Ltd |
タキソールのサイクロデキストリン包接物,その製造法と用途
|
FR2698543B1
(fr)
*
|
1992-12-02 |
1994-12-30 |
Rhone Poulenc Rorer Sa |
Nouvelles compositions à base de taxoides.
|
DK1159974T3
(da)
*
|
1993-07-19 |
2007-11-26 |
Angiotech Pharm Inc |
Antiangiogene sammensætninger indeholdende taxol og en ikke-bionedbrydelig bærer og deres anvendelse
|
US5716981A
(en)
*
|
1993-07-19 |
1998-02-10 |
Angiogenesis Technologies, Inc. |
Anti-angiogenic compositions and methods of use
|
US6335356B1
(en)
|
1994-01-07 |
2002-01-01 |
Sugen, Inc. |
Method of treating a patient by parenteral administration of a lipophilic compound
|
US5610173A
(en)
*
|
1994-01-07 |
1997-03-11 |
Sugen, Inc. |
Formulations for lipophilic compounds
|
AU2826495A
(en)
*
|
1994-06-02 |
1996-01-04 |
Enzon, Inc. |
Method of solubilizing substantially water insoluble materials
|
WO1996003113A1
(en)
*
|
1994-07-22 |
1996-02-08 |
G.D. Searle & Co. |
Self-emulsifying drug delivery system
|
US5681846A
(en)
*
|
1995-03-17 |
1997-10-28 |
Board Of Regents, The University Of Texas System |
Extended stability formulations for paclitaxel
|
US6964946B1
(en)
|
1995-10-26 |
2005-11-15 |
Baker Norton Pharmaceuticals, Inc. |
Oral pharmaceutical compositions containing taxanes and methods of treatment employing the same
|
US6245805B1
(en)
*
|
1995-10-26 |
2001-06-12 |
Baker Norton Pharmaceuticals, Inc. |
Method, compositions and kits for increasing the oral bioavailability of pharmaceutical agents
|
CN1209059A
(zh)
*
|
1995-12-21 |
1999-02-24 |
基因实验室技术有限公司 |
紫杉烷类组合物及方法
|
KR100191446B1
(ko)
*
|
1996-05-02 |
1999-06-15 |
송영욱 |
파클리탁셀 함유 전신성 홍반성 낭창치료제
|
KR100358934B1
(ko)
*
|
1996-09-13 |
2003-01-29 |
주식회사한국신약 |
탁솔을함유한주사용약제조성물
|
US6515016B2
(en)
|
1996-12-02 |
2003-02-04 |
Angiotech Pharmaceuticals, Inc. |
Composition and methods of paclitaxel for treating psoriasis
|
US6458373B1
(en)
*
|
1997-01-07 |
2002-10-01 |
Sonus Pharmaceuticals, Inc. |
Emulsion vehicle for poorly soluble drugs
|
CA2288306A1
(en)
|
1997-04-28 |
1998-11-05 |
Rhone-Poulenc Rorer S.A. |
Adenovirus-mediated intratumoral delivery of an angiogenesis antagonist for the treatment of tumors
|
US6316479B1
(en)
|
1997-05-19 |
2001-11-13 |
Sugen, Inc. |
Isoxazole-4-carboxamide compounds active against protein tryosine kinase related disorders
|
EP0998279B1
(en)
*
|
1997-05-30 |
2002-10-16 |
Man Woo Han |
Pharmaceutical injection solution containing taxol
|
BE1011216A3
(fr)
*
|
1997-06-13 |
1999-06-01 |
Thissen En Abrege L T B Lab |
Forme pharmaceutique pour l'administration de paclitaxel, procede de preparation d'une composition de paclitaxel prete a l'emploi et utilisation de cette composition.
|
US7208010B2
(en)
|
2000-10-16 |
2007-04-24 |
Conor Medsystems, Inc. |
Expandable medical device for delivery of beneficial agent
|
US7208011B2
(en)
*
|
2001-08-20 |
2007-04-24 |
Conor Medsystems, Inc. |
Implantable medical device with drug filled holes
|
US20040254635A1
(en)
*
|
1998-03-30 |
2004-12-16 |
Shanley John F. |
Expandable medical device for delivery of beneficial agent
|
US6241762B1
(en)
|
1998-03-30 |
2001-06-05 |
Conor Medsystems, Inc. |
Expandable medical device with ductile hinges
|
US7314637B1
(en)
|
1999-06-29 |
2008-01-01 |
Neopharm, Inc. |
Method of administering liposomal encapsulated taxane
|
DE19983660T1
(de)
|
1998-10-20 |
2001-09-13 |
Ben Venue Lab Inc |
Verfahren zur Aufreinigung von Lösungsmitteln, die bei der Herstellung von pharmazeutischen Zusammensetzungen nützlich sind
|
US6293967B1
(en)
|
1998-10-29 |
2001-09-25 |
Conor Medsystems, Inc. |
Expandable medical device with ductile hinges
|
US6071952A
(en)
*
|
1998-12-02 |
2000-06-06 |
Mylan Pharmaceuticals, Inc. |
Stabilized injectable pharmaceutical compositions containing taxoid anti-neoplastic agents
|
US6290673B1
(en)
|
1999-05-20 |
2001-09-18 |
Conor Medsystems, Inc. |
Expandable medical device delivery system and method
|
FR2794771B1
(fr)
|
1999-06-11 |
2001-08-10 |
Aventis Pharma Sa |
Adenovirus recombinants codant pour le transporteur specifique de l'iode (nis)
|
AU775373B2
(en)
|
1999-10-01 |
2004-07-29 |
Immunogen, Inc. |
Compositions and methods for treating cancer using immunoconjugates and chemotherapeutic agents
|
WO2003079972A2
(en)
|
2002-02-22 |
2003-10-02 |
New River Parmaceuticals Inc. |
Active agent delivery systems and methods for protecting and administering active agents
|
JP2004511297A
(ja)
|
2000-10-16 |
2004-04-15 |
コナー メドシステムズ, インコーポレイテッド |
有益な薬剤を搬送するための拡張可能な医療装置
|
US6764507B2
(en)
|
2000-10-16 |
2004-07-20 |
Conor Medsystems, Inc. |
Expandable medical device with improved spatial distribution
|
PL203300B1
(pl)
|
2000-10-31 |
2009-09-30 |
Akad Medyczna |
Stabilna postać farmaceutyczna leku przeciwnowotworowego oraz sposób wytwarzania stabilnej postaci farmaceutycznej leku przeciwnowotworowego
|
WO2002043765A2
(en)
|
2000-11-28 |
2002-06-06 |
Transform Pharmaceuticals, Inc. |
Pharmaceutical formulations comprising paclitaxel, derivatives, and pharmaceutically acceptable salts thereof
|
US20040073294A1
(en)
|
2002-09-20 |
2004-04-15 |
Conor Medsystems, Inc. |
Method and apparatus for loading a beneficial agent into an expandable medical device
|
US6964680B2
(en)
*
|
2001-02-05 |
2005-11-15 |
Conor Medsystems, Inc. |
Expandable medical device with tapered hinge
|
KR20020079239A
(ko)
*
|
2001-04-14 |
2002-10-19 |
이언식 |
학습기
|
US7056338B2
(en)
*
|
2003-03-28 |
2006-06-06 |
Conor Medsystems, Inc. |
Therapeutic agent delivery device with controlled therapeutic agent release rates
|
US20040249443A1
(en)
*
|
2001-08-20 |
2004-12-09 |
Shanley John F. |
Expandable medical device for treating cardiac arrhythmias
|
KR100774366B1
(ko)
*
|
2001-09-10 |
2007-11-08 |
주식회사 중외제약 |
파클리탁셀 주사제 조성물
|
US20030101058A1
(en)
*
|
2001-11-26 |
2003-05-29 |
Kenneth Liou |
Voice barcode scan device
|
EP1461056A4
(en)
*
|
2001-11-26 |
2006-01-25 |
Supergen Inc |
PROCESS FOR THE PREPARATION AND USE OF POLYOXYETHYLATED CICRIC OIL IN PHARMACEUTICAL COMPOSITIONS
|
WO2003045357A1
(en)
*
|
2001-11-27 |
2003-06-05 |
Transform Pharmaceuticals, Inc. |
Oral pharmaceutical formulations comprising paclitaxel, derivatives and methods of administration thereof
|
CN100341589C
(zh)
|
2002-05-24 |
2007-10-10 |
血管技术国际股份公司 |
用于涂覆医用植入物的组合物和方法
|
US8313760B2
(en)
*
|
2002-05-24 |
2012-11-20 |
Angiotech International Ag |
Compositions and methods for coating medical implants
|
EP1539043B1
(en)
*
|
2002-09-20 |
2013-12-18 |
Innovational Holdings, LLC |
Expandable medical device with openings for delivery of multiple beneficial agents
|
US20040127976A1
(en)
*
|
2002-09-20 |
2004-07-01 |
Conor Medsystems, Inc. |
Method and apparatus for loading a beneficial agent into an expandable medical device
|
EP1596825A2
(en)
|
2003-02-03 |
2005-11-23 |
Neopharm, Inc. |
Stable sterile filterable liposomal encapsulated taxane and other antineoplastic drugs
|
EP2272544A1
(en)
|
2003-03-28 |
2011-01-12 |
Conor Medsystems, Inc. |
Implantable medical device with beneficial agent concentration gradient
|
US7169179B2
(en)
*
|
2003-06-05 |
2007-01-30 |
Conor Medsystems, Inc. |
Drug delivery device and method for bi-directional drug delivery
|
US7785653B2
(en)
*
|
2003-09-22 |
2010-08-31 |
Innovational Holdings Llc |
Method and apparatus for loading a beneficial agent into an expandable medical device
|
WO2006055008A2
(en)
*
|
2003-11-20 |
2006-05-26 |
Angiotech International Ag |
Implantable sensors and implantable pumps and anti-scarring agents
|
AU2005100176A4
(en)
*
|
2005-03-01 |
2005-04-07 |
Gym Tv Pty Ltd |
Garbage bin clip
|
EP2308467A3
(en)
|
2005-06-17 |
2011-06-22 |
Hospira Australia Pty Ltd |
Liquid pharmaceutical formulations of docetaxel
|
GB0517092D0
(en)
*
|
2005-08-19 |
2005-09-28 |
Novartis Ag |
New compositions containing taxane derivatives
|
BRPI0600194A
(pt)
|
2006-01-30 |
2007-10-23 |
Quiral Quimica Do Brasil S A |
composições farmacêuticas contendo docetaxel e um inibidor de degradação e processo de obtenção das mesmas
|
WO2008026048A2
(en)
*
|
2006-08-31 |
2008-03-06 |
Wockhardt Research Centre |
Stable injectable pharmaceutical compositions of docetaxel
|
EP1946747A1
(en)
*
|
2007-01-17 |
2008-07-23 |
Sandoz AG |
Pharmaceutical composition of improved stability containing taxane derivatives
|
CZ200756A3
(cs)
*
|
2007-01-23 |
2008-07-30 |
Heaton, A. S. |
Dvousložková farmaceutická kompozice obsahující taxan
|
FR2917088B1
(fr)
*
|
2007-06-08 |
2009-09-04 |
Aventis Pharma Sa |
Dissolution directe du docetaxel dans un solvant dans le polysorbate 80
|
KR20100023862A
(ko)
*
|
2007-06-22 |
2010-03-04 |
싸이도우스 엘엘씨. |
트윈 80을 함유하지 않은 도세탁셀의 용해 제제
|
US20090076127A1
(en)
*
|
2007-09-19 |
2009-03-19 |
Protia, Llc |
Deuterium-enriched larotaxel
|
FR2922107B1
(fr)
*
|
2007-10-10 |
2010-02-26 |
Aventis Pharma Sa |
Nouvelles compositions a base de taxoides
|
KR101053780B1
(ko)
*
|
2008-02-29 |
2011-08-02 |
동아제약주식회사 |
도세탁셀을 함유하는 단일액상의 안정한 약제학적 조성물
|
ES2344674B1
(es)
|
2008-08-07 |
2011-06-29 |
Gp Pharm, S.A. |
Composicion farmaceutica inyectable de taxanos.
|
US8541360B2
(en)
*
|
2008-11-19 |
2013-09-24 |
Ben Venue Laboratories, Inc. |
Parenteral formulations comprising sugar-based esters and ethers
|
EP2204167A1
(en)
|
2009-01-05 |
2010-07-07 |
Azad Pharma AG |
Pharmaceutical microemulsion for preventing supramolecular aggregation of amphiphilic molecules
|
US8476310B2
(en)
|
2009-10-19 |
2013-07-02 |
Scidose Llc |
Docetaxel formulations with lipoic acid
|
US8912228B2
(en)
|
2009-10-19 |
2014-12-16 |
Scidose Llc |
Docetaxel formulations with lipoic acid
|
US20110092579A1
(en)
*
|
2009-10-19 |
2011-04-21 |
Scidose Llc |
Solubilized formulation of docetaxel
|
US7772274B1
(en)
|
2009-10-19 |
2010-08-10 |
Scidose, Llc |
Docetaxel formulations with lipoic acid
|
US8541465B2
(en)
*
|
2009-10-19 |
2013-09-24 |
Scidose, Llc |
Docetaxel formulations with lipoic acid and/or dihydrolipoic acid
|
CN102038635A
(zh)
|
2009-10-23 |
2011-05-04 |
天津天士力集团有限公司 |
一种含有pH值调节剂的紫杉烷类药物溶液及其制备方法
|
TWI438009B
(zh)
*
|
2010-02-19 |
2014-05-21 |
Teikoku Pharma Usa Inc |
紫杉烷前-乳劑調配物及其製造與使用之方法
|
KR101752944B1
(ko)
|
2010-05-03 |
2017-07-03 |
테이코쿠 팔마 유에스에이, 인코포레이티드 |
비수성의 탁산 프로에멀젼 제제, 및 그의 제조 및 사용 방법
|
WO2012156999A1
(en)
|
2011-05-19 |
2012-11-22 |
Manu Chaudhary |
Ready to use docetaxel formulation
|
EP2753355B1
(en)
|
2011-09-08 |
2018-10-24 |
New York University |
Oncolytic herpes simplex virus and therapeutic uses thereof
|
WO2013096455A1
(en)
|
2011-12-20 |
2013-06-27 |
Dana-Farber Cancer Institute, Inc. |
Methods for diagnosing and treating oncogenic kras-associated cancer
|
JP2013194009A
(ja)
*
|
2012-03-21 |
2013-09-30 |
Nipro Corp |
ドセタキセル製剤
|
EP2855698A4
(en)
|
2012-05-24 |
2016-03-30 |
Dana Farber Cancer Inst Inc |
TARGETING THE PATHWAY FROM GLUTAMINE TO PYRUVATE TO TREAT CANCER ASSOCIATED WITH ONCOGEN KRAS
|
US20150285802A1
(en)
|
2012-07-18 |
2015-10-08 |
Dana-Farber Cancer Institute, Inc. |
Methods for treating, preventing and predicting risk of developing breast cancer
|
EP2875814B1
(en)
|
2012-07-19 |
2018-08-22 |
FUJIFILM Corporation |
Liquid composition containing taxane-based active ingredient, process for producing same, and liquid medicinal preparation
|
JO3685B1
(ar)
|
2012-10-01 |
2020-08-27 |
Teikoku Pharma Usa Inc |
صيغ التشتيت الجسيمي للتاكسين غير المائي وطرق استخدامها
|
EP2777691A1
(en)
*
|
2013-03-14 |
2014-09-17 |
Pharmachemie B.V. |
Taxoid - Purification of Liquid Excipients
|
WO2014149871A1
(en)
|
2013-03-14 |
2014-09-25 |
Icahn School Of Medicine At Mount Sinai |
Autologous tumor lysate-loaded dendritic cell vaccine for treatment of liver cancer
|
WO2015050844A1
(en)
|
2013-10-01 |
2015-04-09 |
Dana-Farber Cancer Institute, Inc. |
Methods of treating cancer with atovaquone-related compounds
|
PE20211798A1
(es)
|
2014-03-21 |
2021-09-13 |
Abbvie Inc |
Anticuerpos y conjugados de anticuerpo y farmaco anti-egfr
|
WO2015149006A2
(en)
|
2014-03-27 |
2015-10-01 |
Dana-Farber Cancer Institute, Inc. |
Compositions and methods for modulating ncoa4-mediated autophagic targeting of ferritin
|
MA39818A
(fr)
|
2014-03-30 |
2017-02-08 |
Benevir Biopharm Inc |
Virus oncolytiques « armés » comprenant un inhibiteur de tap exogène et leurs utilisations thérapeutiques
|
EP3307330B1
(en)
|
2015-06-15 |
2021-03-10 |
New York University |
Method of treatment using oncolytic viruses
|
US10188626B2
(en)
|
2015-11-03 |
2019-01-29 |
Cipla Limited |
Stabilized cabazitaxel formulations
|
BR112018075653A2
(pt)
|
2016-06-08 |
2019-08-27 |
Abbvie Inc |
anticorpos anti-b7-h3 e conjugados anticorpo fármaco
|
JP2019521973A
(ja)
|
2016-06-08 |
2019-08-08 |
アッヴィ・インコーポレイテッド |
抗bh7−h3抗体及び抗体薬物コンジュゲート
|
CN109562169A
(zh)
|
2016-06-08 |
2019-04-02 |
艾伯维公司 |
抗cd98抗体及抗体药物偶联物
|
CN116284404A
(zh)
|
2016-06-08 |
2023-06-23 |
艾伯维公司 |
抗b7-h3抗体和抗体药物偶联物
|
MX2018015272A
(es)
|
2016-06-08 |
2019-08-12 |
Abbvie Inc |
Anticuerpos anti-cd98 y conjugados de anticuerpo y farmaco.
|
JP6292267B2
(ja)
*
|
2016-09-13 |
2018-03-14 |
ニプロ株式会社 |
ドセタキセル製剤
|
AU2018328532A1
(en)
|
2017-09-07 |
2020-04-23 |
Ningbo Combireg Pharmaceutical Technology Co., Ltd |
Pharmaceutical composition of docetaxel conjugate and preparation method
|
JP2018115178A
(ja)
*
|
2018-03-15 |
2018-07-26 |
ニプロ株式会社 |
ドセタキセル製剤
|
US20210322304A1
(en)
|
2018-09-05 |
2021-10-21 |
Emcure Pharmaceuticals Ltd. |
Stable ready-to-use carmustine pharmaceutical composition
|
AR124681A1
(es)
|
2021-01-20 |
2023-04-26 |
Abbvie Inc |
Conjugados anticuerpo-fármaco anti-egfr
|